Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Ottawa

$27,000.00

Myocardial xCT and glutathione redox in metabolic resilience and mitigation of ferroptosis in ischemic cardiomyopathy

EF 2025-26

Résumé
Heart failure is a serious health issue that affects one in five Canadians and is a major cause of death worldwide. The most common reason for heart failure is a condition called ischemic cardiomyopathy, which happens due to heart artery disease and heart attacks. To help patients and reduce death and hospitalization, doctors use strategies to save heart tissue. It’s crucial to restore blood flow to the heart quickly after a blockage, but doing so can sometimes further injure the heart. When the heart doesn’t get enough blood, it can’t produce enough energy (ATP), which is vital for the heart to function properly. During this time, a substance called succinate builds up, and when blood flow returns, it can lead to the production of harmful molecules that damage the heart even more. This damage can cause a specific type of cell death known as ferroptosis, which is linked to problems with metabolism, oxidative stress, and iron levels in the cells. Glutathione is an important molecule that helps to protect the heart cells from damage. An imbalance in glutathione levels can lead to cell stress, including problems with iron and fat metabolism, triggering ferroptosis. The balance of glutathione depends on its ongoing production in cells, which requires a substance called cystine. Cystine enters cells through a protein called xCT and is converted into cysteine, which is necessary for making glutathione. We believe that xCT helps to prevent heart cell death by maintaining glutathione levels and supporting energy production in the mitochondria, thus protecting against damage from the lack of blood flow. Our goal is to study these processes in mouse models and cell systems to see if xCT is a good target for future treatments of heart failure caused by blood flow issues.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572889
Name
Amini Farzaneh
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Myocardial xCT and glutathione redox in metabolic resilience and mitigation of ferroptosis in ischemic cardiomyopathy
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Ferroptosis; Glutathione Redox; Ischemia-Reperfusion Injury; Ischemic Cardiomyopathy; Myocardial Xct; Reactive Oxygen Species; Succinate
Abstract
Heart failure is a serious health issue that affects one in five Canadians and is a major cause of death worldwide. The most common reason for heart failure is a condition called ischemic cardiomyopathy, which happens due to heart artery disease and heart attacks. To help patients and reduce death and hospitalization, doctors use strategies to save heart tissue. It’s crucial to restore blood flow to the heart quickly after a blockage, but doing so can sometimes further injure the heart. When the heart doesn’t get enough blood, it can’t produce enough energy (ATP), which is vital for the heart to function properly. During this time, a substance called succinate builds up, and when blood flow returns, it can lead to the production of harmful molecules that damage the heart even more. This damage can cause a specific type of cell death known as ferroptosis, which is linked to problems with metabolism, oxidative stress, and iron levels in the cells. Glutathione is an important molecule that helps to protect the heart cells from damage. An imbalance in glutathione levels can lead to cell stress, including problems with iron and fat metabolism, triggering ferroptosis. The balance of glutathione depends on its ongoing production in cells, which requires a substance called cystine. Cystine enters cells through a protein called xCT and is converted into cysteine, which is necessary for making glutathione. We believe that xCT helps to prevent heart cell death by maintaining glutathione levels and supporting energy production in the mitochondria, thus protecting against damage from the lack of blood flow. Our goal is to study these processes in mouse models and cell systems to see if xCT is a good target for future treatments of heart failure caused by blood flow issues.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Amini, Farzaneh
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~